Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of COVID-19 Vaccines on Cerebrovascular Health - a Population-based Study

NCT04992195 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT04992195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04992195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of COVID-19 Vaccines on Cerebrovascular Health - a Population-based Study
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
July 5, 2021
Completion date
March 31, 2026
Enrollment
415 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, arterial thromboembolism, brain diseases, brain ischemia, dementia, major adverse cardiovascular event, stroke, stroke, acute, stroke, ischemic, venous thromboembolism